Mast Therapeutics, Inc. (MSTX)

[xtreem99]

i was just floating an idea. and i dont drink coffee, it makes me paranoid. LOL just kidding.

but i think it is definitely possible. 530(20-50mil rev) and 514(200mill rev) potential, do you know what these new reformulations would do to Glaxo? not much, but it would irritate them enough to buy out. LOL
dont forget, this stock started under a buck, and peaked at over 5 with one drug in the works at that time. and hovered at above 2 dollars for over 2 years.
there was less dilution then, but still, if this company hits 2 successful nda's in one year, with the backing of ICAHN name even minutely involved, with all the other cancer bios getting big publicity, and Glaxo or Lilly hovering for a buy, this year may be the "perfect storm" dont forget, ANX is not only preparing 2 new drugs, they are setting a new precedent with the technology as well.
how many drugs could benifit from less side effects from injection?
i can think of a few.
i'm already in for the long haul, we will see what happens.
thanks for the reply!
Good luck to All!